Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

International Society for Advancement of Cytometry (ISAC) flow cytometry shared resource laboratory (SRL) best practices.

Barsky LW, Black M, Cochran M, Daniel BJ, Davies D, DeLay M, Gardner R, Gregory M, Kunkel D, Lannigan J, Marvin J, Salomon R, Torres C, Walker R.

Cytometry A. 2016 Nov;89(11):1017-1030. doi: 10.1002/cyto.a.23016. Epub 2016 Nov 3.

PMID:
27813253
2.

Multiple microRNA regulation of lipoprotein lipase gene abolished by 3'UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter.

Caussy C, Charrière S, Meirhaeghe A, Dallongeville J, Lefai E, Rome S, Cuerq C, Euthine V, Delay M, Marmontel O, Di Filippo M, Lagarde M, Moulin P, Marçais C.

Atherosclerosis. 2016 Mar;246:280-6. doi: 10.1016/j.atherosclerosis.2016.01.010. Epub 2016 Jan 11.

PMID:
26820803
3.

Short and long term biosorption of silica-coated iron oxide nanoparticles in heterotrophic biofilms.

Herrling MP, Lackner S, Tatti O, Guthausen G, Delay M, Franzreb M, Horn H.

Sci Total Environ. 2016 Feb 15;544:722-9. doi: 10.1016/j.scitotenv.2015.11.174. Epub 2015 Dec 10.

PMID:
26674701
4.

Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.

Le Bel J, Hausfater P, Chenevier-Gobeaux C, Blanc FX, Benjoar M, Ficko C, Ray P, Choquet C, Duval X, Claessens YE; ESCAPED study group.

Crit Care. 2015 Oct 16;19:366. doi: 10.1186/s13054-015-1083-6.

5.

Magnetic resonance imaging reveals detailed spatial and temporal distribution of iron-based nanoparticles transported through water-saturated porous media.

Cuny L, Herrling MP, Guthausen G, Horn H, Delay M.

J Contam Hydrol. 2015 Nov;182:51-62. doi: 10.1016/j.jconhyd.2015.08.005. Epub 2015 Aug 24.

PMID:
26335945
6.

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators.

Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1.

7.

Low biosorption of PVA coated engineered magnetic nanoparticles in granular sludge assessed by magnetic susceptibility.

Herrling MP, Fetsch KL, Delay M, Blauert F, Wagner M, Franzreb M, Horn H, Lackner S.

Sci Total Environ. 2015 Dec 15;537:43-50. doi: 10.1016/j.scitotenv.2015.07.161. Epub 2015 Aug 14.

PMID:
26282738
8.

Scaling up nanoscale water-driven energy conversion into evaporation-driven engines and generators.

Chen X, Goodnight D, Gao Z, Cavusoglu AH, Sabharwal N, DeLay M, Driks A, Sahin O.

Nat Commun. 2015 Jun 16;6:7346. doi: 10.1038/ncomms8346.

9.

DEK over-expression promotes mitotic defects and micronucleus formation.

Matrka MC, Hennigan RF, Kappes F, DeLay ML, Lambert PF, Aronow BJ, Wells SI.

Cell Cycle. 2015;14(24):3939-53. doi: 10.1080/15384101.2015.1044177. Epub 2015 May 6.

10.

Antibacterial activity of sulfamethoxazole transformation products (TPs): general relevance for sulfonamide TPs modified at the para position.

Majewsky M, Wagner D, Delay M, Bräse S, Yargeau V, Horn H.

Chem Res Toxicol. 2014 Oct 20;27(10):1821-8. doi: 10.1021/tx500267x. Epub 2014 Sep 11.

PMID:
25211553
11.

Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.

Maury P, Audoubert M, Cintas P, Rollin A, Duparc A, Mondoly P, Chiriac AM, Acket B, Zhao X, Pasquié JL, Cardin C, Delay M, Sadron M, Carrié D, Galinier M, Davy JM, Arne-Bès MC, Raczka F.

Heart Rhythm. 2014 Oct;11(10):1721-7. doi: 10.1016/j.hrthm.2014.07.011. Epub 2014 Jul 9.

PMID:
25016148
12.

Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.

Di Filippo M, Marçais C, Charrière S, Marmontel O, Broyer M, Delay M, Merlin M, Nollace A, Valéro R, Lagarde M, Pruneta-Deloche V, Moulin P, Sassolas A.

PLoS One. 2014 Jun 2;9(6):e99721. doi: 10.1371/journal.pone.0099721. eCollection 2014.

13.

Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.

Di Filippo M, Marçais C, Charrière S, Marmontel O, Broyer M, Delay M, Merlin M, Nollace A, Valéro R, Lagarde M, Pruneta-Deloche V, Moulin P, Sassolas A.

PLoS One. 2014 May 2;9(5):e96482. doi: 10.1371/journal.pone.0096482. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e99721.

14.

Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.

Maury P, Baratto F, Zeppenfeld K, Klein G, Delacretaz E, Sacher F, Pruvot E, Brigadeau F, Rollin A, Andronache M, Maccabelli G, Gawrysiak M, Brenner R, Forclaz A, Schlaepfer J, Lacroix D, Duparc A, Mondoly P, Bouisset F, Delay M, Hocini M, Derval N, Sadoul N, Magnin-Poull I, Klug D, Haïssaguerre M, Jaïs P, Della Bella P, De Chillou C.

Eur Heart J. 2014 Jun 7;35(22):1479-85. doi: 10.1093/eurheartj/ehu040. Epub 2014 Feb 16.

PMID:
24536081
15.

An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site.

Caussy C, Charrière S, Marçais C, Di Filippo M, Sassolas A, Delay M, Euthine V, Jalabert A, Lefai E, Rome S, Moulin P.

Am J Hum Genet. 2014 Jan 2;94(1):129-34. doi: 10.1016/j.ajhg.2013.12.001.

16.

Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome.

Maury P, Rollin A, Sacher F, Gourraud JB, Raczka F, Pasquié JL, Duparc A, Mondoly P, Cardin C, Delay M, Derval N, Chatel S, Bongard V, Sadron M, Denis A, Davy JM, Hocini M, Jaïs P, Jesel L, Haïssaguerre M, Probst V.

Am J Cardiol. 2013 Nov 1;112(9):1384-9. doi: 10.1016/j.amjcard.2013.06.033. Epub 2013 Sep 3.

PMID:
24011739
17.

Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress.

Ameri K, Rajah AM, Nguyen V, Sanders TA, Jahangiri A, Delay M, Donne M, Choi HJ, Tormos KV, Yeghiazarians Y, Jeffrey SS, Rinaudo PF, Rowitch DH, Aghi M, Maltepe E.

PLoS One. 2013 Apr 30;8(4):e62758. doi: 10.1371/journal.pone.0062758. Print 2013.

18.

β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.

Carbonell WS, DeLay M, Jahangiri A, Park CC, Aghi MK.

Cancer Res. 2013 May 15;73(10):3145-54. doi: 10.1158/0008-5472.CAN-13-0011. Epub 2013 May 3.

19.

Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome.

Rollin A, Sacher F, Gourraud JB, Pasquié JL, Raczka F, Duparc A, Mondoly P, Cardin C, Delay M, Chatel S, Derval N, Denis A, Sadron M, Davy JM, Hocini M, Jaïs P, Jesel L, Haïssaguerre M, Probst V, Maury P.

Heart Rhythm. 2013 Jul;10(7):1012-8. doi: 10.1016/j.hrthm.2013.03.001. Epub 2013 Mar 14.

PMID:
23499630
20.

Slower heart rate and altered rate dependence of ventricular repolarization in patients with lone atrial fibrillation.

Maury P, Caudron G, Bouisset F, Fourcade J, Duparc A, Mondoly P, Rollin A, Hascoët S, Detis N, Cardin C, Delay M, Lairez O, Roncalli J, Galinier M, Carrié D, Elbaz M, Ferrières J, Fauvel JM, Zimmermann M.

Arch Cardiovasc Dis. 2013 Jan;106(1):12-8. doi: 10.1016/j.acvd.2012.10.001. Epub 2012 Dec 29.

Supplemental Content

Loading ...
Support Center